scispace - formally typeset
G

Glyn Lewis

Researcher at University College London

Publications -  768
Citations -  57050

Glyn Lewis is an academic researcher from University College London. The author has contributed to research in topics: Population & Longitudinal study. The author has an hindex of 113, co-authored 734 publications receiving 49316 citations. Previous affiliations of Glyn Lewis include University College Hospital & St Bartholomew's Hospital.

Papers
More filters
Journal ArticleDOI

Characterisation of zuclopenthixol metabolism by in vitro and therapeutic drug monitoring studies.

TL;DR: Characterisation of zuclopenthixol metabolism by in vitro and therapeutic drug monitoring studies and its role in apoptosis and drug resistance is investigated.
Journal ArticleDOI

Childhood facial emotion recognition and psychosis-like symptoms in a nonclinical population at 12 years of age: results from the ALSPAC birth cohort.

TL;DR: Deficits in facial emotion recognition in 8-year-olds do not appear to predict later reporting of nonclinical psychotic symptoms in early adolescence, and the results do not support the proposal that recognition of emotion is a trait phenomenon in those individuals at increased risk for psychosis.
Journal ArticleDOI

Curiosity killed the cat: no evidence of an association between cat ownership and psychotic symptoms at ages 13 and 18 years in a UK general population cohort

TL;DR: This study strongly indicates that cat ownership in pregnancy or early childhood does not confer an increased risk of later adolescent PEs, and pregnant women should continue to avoid handling soiled cat litter.
Journal ArticleDOI

MRI Indices of Cortical Development in Young People with Psychotic Experiences: Influence of Genetic Risk and Persistence of Symptoms

TL;DR: Disturbances in lGI were similar to schizophrenia but findings were mostly limited to those with persistent PEs, suggesting early disturbances in cortical expansion rather than progressive changes in brain structure.
Journal ArticleDOI

Effective dose 50 method as the minimal clinically important difference: Evidence from depression trials.

TL;DR: In this paper, the authors used secondary data from two randomised controlled trials for depression (n=1,122) to calibrate the Global Rating of Change with the PHQ-9 and GAD-7 to identify the minimal clinically important difference (MCID) across the spectrum of baseline severity.